Nektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty...

|About: Nektar Therapeutics (NKTR)|By:, SA News Editor

Nektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty Pharma for $124M. The company plans to use the net proceeds of the transaction towards the repayment of its $215M in convertible debt. Shares are currently under a trading halt.